ESC & iPSC News 14.29 July 31, 2019 | |
| |
TOP STORYNanoscale Architecture of the Cortical Actin Cytoskeleton in Embryonic Stem Cells Using super-resolution microscopy to investigate the actin cytoskeleton in mouse ESCs, scientists observed that the actin cortex consisted of a distinctively sparse and isotropic network. [Cell Rep] Full Article | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Investigators explored the role of SET and MYND domain‐containing protein 2 (SMYD2) in the self‐renewal and mesendodermal lineage commitment of human ESCs (hESCs). They demonstrated that the expression of SMYD2 was significantly enhanced during mesendodermal but not neuroectodermal differentiation of hESCs. [Stem Cells] Abstract Researchers used human ESCs as a model to demonstrate that elevated exogenous pyruvate shifts metabolic balance toward oxidative phosphorylation in both maintenance and differentiation conditions. [Stem Cell Reports] Full Article | Graphical Abstract Feasibility of suspension culture based human PSC-cardiomyocyte production in low-cost, xeno-free media compatible with good manufacturing practice standards is shown. [Stem Cell Reports] Full Article | Graphical Abstract Currently, megakaryocytes can be generated from iPSCs to study platelet production under pharmacological or genetic manipulations. Researchers generated iPSC lines from two Bernard-Soulier syndrome patients with mutations in different genes. [Thromb Haemost] Abstract The authors combined transcriptome, proteome and phosphoproteome profiling to perform an in-depth, multi-omics study of the human ESCs-to-mesenchymal stem/stromal cells differentiation process. [Mol Cell Proteomics] Abstract Insulin improved the seeding and proliferation of human induced PSCs (hiPSCs). They also observed an altered cell cycle profile and an increase in apoptosis in hiPSCs in the absence of insulin. [Stem Cell Res Ther] Full Article Scientists indicated that knockdown of CCDC144NL-AS1 induced naïve-like state conversion of human PSCs in the absence of additional transcription factors or small molecular inhibitors. [Stem Cell Res Ther] Full Article Human iPSC-lines of Indian origin NCCSi005A and NCCSi006A were established by reprogramming of CD4+ T cells, isolated from the peripheral blood mononuclear cells of two healthy female donors. [Stem Cell Res] Full Article Generation of CDMLe012-A-1 Cells: A Pluripotent Human Embryonic Stem Cell Model of Turner’s Syndrome The CDMLe012-A-1 human ESC line, derived from a day six blastocyst with a normal 46,XX female karyotype spontaneously lost an X-chromosome during cell culture. [Stem Cell Res] Full Article Subscribe to one of our other 19 science newsletters such as Cell Therapy News & Mesenchymal Cell News. | |
| |
REVIEWSThe Role of Telomere-Binding Modulators in Pluripotent Stem Cells The authors discuss how telomeres and telomere-associated factors participate in and regulate the maintenance of stem cell pluripotency. [Protein Cell] Full Article Concise Review: Epigenetic Regulation of Transition among Different Pluripotent States Researchers reviewed studies on various pluripotent states, with a highlight on the epigenetic regulation during the interconversion. [Stem Cells] Abstract Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field. | |
| |
INDUSTRY NEWSBioTime Announces Name Change to Lineage Cell Therapeutics BioTime, Inc. announced it is launching a new corporate brand, including a change of its corporate name to Lineage Cell Therapeutics, Inc., effective August 12, 2019. [BioTime, Inc.] Press Release SpaceX Dragon en Route to Space Station with NASA Science, Cargo A SpaceX Dragon cargo spacecraft is on its way to deliver the second commercial crew docking port and about 5,000 pounds of science investigations and supplies for the International Space Station. [National Aeronautics and Space Administration] Press Release | |
| |
POLICY NEWSJapan Approves First Human-Animal Embryo Experiments A Japanese stem-cell scientist is the first to receive government support to create animal embryos that contain human cells and transplant them into surrogate animals since a ban on the practice was overturned earlier this year. Hiromitsu Nakauchi, who leads teams at the University of Tokyo and Stanford University in California, plans to grow human cells in mouse and rat embryos and then transplant those embryos into surrogate animals. [Nature News] Editorial NIH Announces Details of Human Fetal Tissue Research Restrictions On July 26, the National Institutes of Health announced new restrictions on human fetal tissue research for scientists applying for grants using the material from elective abortions. Starting in September, scientists writing grants for experiments that involve this type of fetal tissue will be required to explain why other tissue types can’t be used and where the researchers plan to get the tissue. [The Scientist] Editorial China’s Scientists Alarmed, Bewildered by Growing Anti-Chinese Sentiment in the United States Scientists in China are concerned about what they see as growing anti-Chinese sentiment in the United States. They dismiss claims of a vast conspiracy to steal US intellectual property and worry that new visa restrictions, scrutiny of export of scientific devices, and US investigations of Chinese and Chinese American scientists will hinder international collaborations. That could harm both countries’ research efforts as well as global scientific progress, many say. [ScienceInsider] Editorial UK Prime Minister Boris Johnson’s Hardline Brexit Stance Stokes Fears for Scientists In his inaugural speech last week, Johnson cited the “extraordinary” UK bioscience sector and pledged to ditch European rules that he says have hampered the development of genetically modified crops. He said the nation should develop its own multibillion-dollar GPS satellite system, presumably a response to the EU plan to eliminate the ability of the U.K. government to tap into a secure signal from the European Galileo GPS system. [ScienceInsider] Editorial
| |
EVENTSNEW Wnt Signaling Networks in Development, Disease and Regeneration Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Associate – Cancer and Glioma Stem Cell Biology (Weill Cornell Medicine) Scientific Communications Coordinator (STEMCELL Technologies Inc.) Research Technologist – Pluripotent Stem Cell Biology (STEMCELL Technologies Inc.) Scientist – Stem Cell Metabolism (STEMCELL Technologies Inc.) Postdoctoral Fellow Positions – Cancer Research (Nationwide Children’s Hospital) Research Technician – Beta Cell Production from Human PSCs (Helmholtz Zentrum München) Senior Scientist – Cell Engineering and Characterization (Merck & Co., Inc) Associate Professor – Developmental and Stem Cell Biology (The University of Hong Kong) Postdoctoral Fellows – Striated Muscle Regeneration (Duke University) Postdoctoral Researcher – Cystic Fibrosis Stem Cell Models (The University of Alabama at Birmingham) Postdoctoral Fellow – Pluripotent Stem Cells & Joint Tissue Development (Boston Children’s Hospital) Postdoctoral Fellow – Genetics and Epigenomics of iPSC Biology (Stanford University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in ESC & iPSC News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|